Literature DB >> 22169097

Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.

Hanshao Liu1, Lin Zhu, Bingya Liu, Liu Yang, Xianxin Meng, Wei Zhang, Yueyun Ma, Huasheng Xiao.   

Abstract

Recent studies demonstrated that in several human malignancies aberrant expression profiles of circulating microRNAs (miRNAs) anticipate great cancer diagnostic potential. Here we showed that serum miR-378 could serve as a novel noninvasive biomarker in gastric cancer (GC) detection. Genome-wide miRNA expression profiles followed with Real-Time quantitative RT-PCR (qRT-PCR) assays revealed that miR-187(*), miR-371-5p and miR-378 were significantly elevated in GC patients. Further validation indicated that miR-378 alone could yields a ROC curve area of 0.861 with 87.5% sensitivity and 70.73% specificity in discriminating GC patients from healthy controls. Collectively, these data support our contention that serum miR-378 has strong potential as a novel noninvasive biomarker in gastric cancer detection.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169097     DOI: 10.1016/j.canlet.2011.10.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  113 in total

1.  Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.

Authors:  Leila Sisic; Daniel Vallböhmer; Nikolas H Stoecklein; Susanne Blank; Thomas Schmidt; Christiane Driemel; Birte Möhlendick; Wolfram T Knoefel; Margarete Odenthal; Katja Ott
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

2.  Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.

Authors:  Mao-Song Lin; Wei-Chang Chen; Jun-Xing Huang; Heng-Jun Gao; Hai-Hui Sheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer.

Authors:  Xiao-Feng Zeng; Juan Li; Sheng-Bin Li
Journal:  Tumour Biol       Date:  2013-07-31

Review 4.  The role of miR-148a in gastric cancer.

Authors:  Jiazeng Xia; Xiaoqiang Guo; Jiang Yan; Kaiyuan Deng
Journal:  J Cancer Res Clin Oncol       Date:  2014-09       Impact factor: 4.553

5.  Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.

Authors:  Qinghai Zeng; Cuihong Jin; Wenhang Chen; Fang Xia; Qi Wang; Fan Fan; Juan Du; Yihang Guo; Changwei Lin; Kaiyan Yang; Jingjing Li; Xiaowei Peng; Xiaorong Li; Ke Cao
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

Review 6.  Non-coding RNAs underlying chemoresistance in gastric cancer.

Authors:  Arash Poursheikhani; Zahra Bahmanpour; Ehsan Razmara; Ladan Mashouri; Mohammad Taheri; Dorsa Morshedi Rad; Hassan Yousefi; Amirreza Bitaraf; Sadegh Babashah
Journal:  Cell Oncol (Dordr)       Date:  2020-06-03       Impact factor: 6.730

Review 7.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 8.  Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Authors:  Ming-hui Li; Sheng-bo Fu; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

Review 9.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

10.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.